"Clínica Dávila es uno de los principales centros privados hospitalarios del país, orientado a satisfacer las necesidades de salud de las personas, para lo que cuenta con todas las especialidades médicas y unidades de tratamiento intensivo e intermedio, para pacientes adultos, infantiles y recién nacidos. Nuestra misión es ayudar a las personas a llevar vidas más saludables y colaborar para que el sistema de salud funcione mejor para todos."

During the past decade, Clínica Dávila conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clínica Dávila" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Fresenius Kabi" with 1 trials sponsored, "Helsinn Healthcare SA" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Dávila" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "Jain Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clínica Dávila" are "Amyotrophic Lateral Sclerosis" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Atrial Fibrillation" (1 trials), "Caloric Deficit" (1 trials) and "Chemotherapy-Induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Clínica Dávila" in a lesser frequency.

Most popular intervention types in "Clínica Dávila" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASA 100 mg" (1 trials), "Acthar" (1 trials), "Belimumab 1 mg/kg" (1 trials) and "Belimumab 10 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Dávila" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Clínica Dávila". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clínica Dávila, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Dávila, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".